Cargando…

Cost-effectiveness Analysis of Cetuximab in Treatment of Metastatic Colorectal Cancer in Iranian Pharmaceutical Market

BACKGROUND: Cetuximab is a monoclonal antibody which acts against the epidermal growth-factor receptor. Randomized controlled trials show that the addition of cetuximab to folinic acid, 5-flourouracil, irinotecan (FOLFIRI), folinic acid, 5-flourouracil, oxaliplatin (FOLFOX) and capecitabin + oxalipl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davari, Majid, Ashrafi, Farzaneh, Maracy, Mohammadreza, Aslani, Abolfazl, Tabatabaei, Mohammadreza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521302/ https://www.ncbi.nlm.nih.gov/pubmed/26288707 http://dx.doi.org/10.4103/2008-7802.161068

Ejemplares similares

The Direct Medical Costs of Colorectal Cancer in Iran; Analyzing the Patient's Level Data from a Cancer Specific Hospital in Isfahan
por: Davari, Majid, et al.
Publicado: (2012)

Impacts of international sanctions on Iranian pharmaceutical market
por: Cheraghali, Abdol Majid
Publicado: (2013)

A Japanese Post-marketing Surveillance of Cetuximab (Erbitux(®)) in Patients with Metastatic Colorectal Cancer
por: Ishiguro, Megumi, et al.
Publicado: (2012)

Cost-effectiveness of cetuximab and panitumumab for chemotherapy-refractory metastatic colorectal cancer
por: Carvalho, Adriana Camargo, et al.
Publicado: (2017)

The Direct Medical Costs of Outpatient Cares of Type 2 Diabetes in Iran: A Retrospective Study
por: Davari, Majid, et al.
Publicado: (2016)

Cetuximab treatment in a patient with metastatic colorectal cancer and psoriasis
por: Neyns, B., et al.
Publicado: (2008)

The Direct Medical Costs of Breast Cancer in Iran: Analyzing the Patient's Level Data from a Cancer Specific Hospital in Isfahan
por: Davari, Majid, et al.
Publicado: (2013)

Measuring Equity in Access to Pharmaceutical Services Using Concentration Curve; Model Development
por: Davari, Majid, et al.
Publicado: (2015)

First-line targeted therapies in the treatment of metastatic colorectal cancer – role of cetuximab
por: Tonini, Giuseppe, et al.
Publicado: (2009)

Economic and non-economic determinants of Iranian pharmaceutical companies’ financial performance: an empirical study
por: Masoumi, Mohammadreza, et al.
Publicado: (2019)

Cost-effectiveness of FOLFOX6+Bevacizumab Versus FOLFOX6+Cetuximab in Stage IV Colorectal Cancer Patients in Shiraz, Iran
por: Jafari, Abdosaleh, et al.
Publicado: (2023)

Real-world cost-effectiveness of cetuximab in the third-line treatment of metastatic colorectal cancer based on patient chart review in the Netherlands
por: Uyl-de Groot, Carin A., et al.
Publicado: (2018)

RAS testing and cetuximab treatment for metastatic colorectal cancer: a cost-effectiveness analysis in a setting with limited health resources
por: Wu, Bin, et al.
Publicado: (2017)

Trends in Iran Pharmaceutical Market
por: Cheraghali, Abdol Majid
Publicado: (2017)

A Fourteen-day Experience with Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS): An Iranian Treatment Protocol
por: Jamaati, Hamidreza, et al.
Publicado: (2020)

Current status of treatment of metastatic colorectal cancer with special reference to cetuximab and elderly patients
por: Pfeiffer, Per, et al.
Publicado: (2009)

Molecular targeted treatment of metastatic colorectal cancer: the cardiovascular adverse effects of Bevacizumab and Cetuximab
por: GHERMAN, ALEXANDRA, et al.
Publicado: (2017)

Diet and The Risk of Endometriosis in Iranian Women: A Case-Control Study
por: Ashrafi, Mahnaz, et al.
Publicado: (2020)

Cost-effectiveness and cost-utility analysis of OTC use of simvastatin 10 mg for the primary prevention of myocardial infarction in Iranian men
por: Amirsadri, Mohammadreza, et al.
Publicado: (2015)

Effectiveness and Costs Associated to Adding Cetuximab or Bevacizumab to Chemotherapy as Initial Treatment in Metastatic Colorectal Cancer: Results from the Observational FABIO Project
por: Franchi, Matteo, et al.
Publicado: (2020)

Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancer
por: Jehn, C F, et al.
Publicado: (2012)

Optimising the use of cetuximab in the continuum of care for patients with metastatic colorectal cancer
por: Goldberg, Richard M, et al.
Publicado: (2018)

Genetic and immune factors underlying the efficacy of cetuximab and panitumumab in the treatment of patients with metastatic colorectal cancer
por: Krawczyk, Paweł Adam, et al.
Publicado: (2013)

Cetuximab could be more effective without prior bevacizumab treatment in metastatic colorectal cancer patients
por: Sato, Yasuyoshi, et al.
Publicado: (2015)

Encorafenib plus cetuximab for the treatment of BRAF-V600E-mutated metastatic colorectal cancer
por: Ros, Javier, et al.
Publicado: (2022)

Cost-effectiveness of surgical excision versus Mohs micrographic surgery for nonmelanoma skin cancer: A retrospective cohort study
por: Nassiripour, Leila, et al.
Publicado: (2016)

Evolving role of cetuximab in the treatment of colorectal cancer
por: Schuch, Gunter, et al.
Publicado: (2009)

Consequences of Biomarker Analysis on the Cost-Effectiveness of Cetuximab in Combination with FOLFIRI as a First-Line Treatment of Metastatic Colorectal Cancer: Personalised Medicine at Work
por: Harty, Gerard, et al.
Publicado: (2018)

Nanodrugs and Natural Pharmaceutical Products
por: Abbaspour, Mohammadreza
Publicado: (2012)

PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients
por: Frattini, M, et al.
Publicado: (2007)

Strategy-making Process and Firm Performance in Iranian Pharmaceutical Industry
por: Abolfazli, Seyyed Abolfazl, et al.
Publicado: (2019)

Chemotherapeutic Effectiveness of Combining Cetuximab for Metastatic Colorectal Cancer Treatment: A System Review and Meta-Analysis
por: Li, Rong, et al.
Publicado: (2020)

Complete Response With Cetuximab-Based Treatment of Metastatic Colorectal Cancers: Two Case Reports and Literature Review
por: Wei, Li, et al.
Publicado: (2022)

Cetuximab retreatment in patients with metastatic colorectal cancer who exhibited a clinical benefit in response to prior cetuximab: A retrospective study
por: Tanioka, Hiroaki, et al.
Publicado: (2018)

Cetuximab in the management of colorectal cancer
por: Lenz, Heinz-Josef
Publicado: (2007)

The Effect of Active Treatment and Visit Compared to Conventional Treatment, on Preventing Recurrent Suicidal Attempts: A Randomized Controlled Clinical Trial
por: Mousavi, Seyed Ghafur, et al.
Publicado: (2017)

Iranian Pharmacists’ Knowledge, Attitude and Practice Regarding Counterfeit Drugs
por: Shahverdi, Shieda, et al.
Publicado: (2012)

Vitamin B12 and Folate Status in Patients with Epilepsy Under Levetiracetam Monotherapy
por: Mahdavi, Atena, et al.
Publicado: (2019)

The MTHFR C677T polymorphism influences the efficacy of folic acid supplementation on the nerve conduction studies in patients with diabetic polyneuropathy; A randomized, double blind, placebo-controlled study
por: Mottaghi, Tayebeh, et al.
Publicado: (2019)

The impact of external reference pricing on pharmaceutical costs and market dynamics
por: Voehler, Dominic, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_unnp10m2b8o89902gek37rrpkn